Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Organ Rejection”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableLooking for participantsNCT02423070
What this trial is testing

Genome Transplant Dynamics

Who this might be right for
Thoracic Organ Transplantation
National Heart, Lung, and Blood Institute (NHLBI) 991
Not applicableStudy completedNCT00056784
What this trial is testing

The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 134
Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Not applicableWithdrawnNCT04827186
What this trial is testing

Spleen Transplant in Solid Organ Transplantation

Who this might be right for
Kidney Transplant RejectionPositive FCXM (T or B Cell Positive)Positive CDC Cross-Match (B Cell Positive)+1 more
University of Illinois at Chicago
Testing effectiveness (Phase 2)Study completedNCT00076570
What this trial is testing

Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31
Not applicableStudy completedNCT00096733
What this trial is testing

Adult-to-Adult Living Donor Liver Transplantation Study

Who this might be right for
CirrhosisHepatitis CHepatocellular Carcinoma
Arbor Research Collaborative for Health 2,470
Testing effectiveness (Phase 2)WithdrawnNCT01649388
What this trial is testing

A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

Who this might be right for
Kidney Transplantation
Talaris Therapeutics Inc.
Not applicableStudy completedNCT00893919
What this trial is testing

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Who this might be right for
Prophylaxis of Organ Rejection
Roxane Laboratories 37
Testing effectiveness (Phase 2)Looking for participantsNCT07053488
What this trial is testing

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Who this might be right for
Liver DiseasesLiver CancerLiver Cirrhosis+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Not applicableLooking for participantsNCT01163578
What this trial is testing

Biomarkers in Transplant Recipients to Improve Outcomes

Who this might be right for
Solid Organ TransplantationBone Marrow Transplantation
University of Pittsburgh 1,200
Not applicableEnded earlyNCT03439995
What this trial is testing

Goal of Open Lung Ventilation in Donors

Who this might be right for
Brain DeathOrgan DonationOrgan Transplant Failure or Rejection
Vanderbilt University Medical Center 154
Early research (Phase 1)Study completedNCT01236378
What this trial is testing

Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients

Who this might be right for
Transplant RejectionRenal Transplantation
Pfizer 24
Not applicableStudy completedNCT02382211
What this trial is testing

T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays

Who this might be right for
Infection in Solid Organ Transplant Recipients
Oxford Immunotec 600
Post-approval studies (Phase 4)Study completedNCT01656135
What this trial is testing

Reference Group Trial for The ONE Study

Who this might be right for
End-stage Renal FailureKidney Graft Rejection
University of Regensburg 70
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Testing effectiveness (Phase 2)Study completedNCT00734396
What this trial is testing

Mesenchymal Stem Cells and Subclinical Rejection

Who this might be right for
Organ Transplantation
Leiden University Medical Center 15
Very early researchStudy completedNCT03626714
What this trial is testing

Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study

Who this might be right for
Organ Transplant RejectionPsoriasis
Auritec Pharmaceuticals 8
Not applicableLooking for participantsNCT06982404
What this trial is testing

ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biopsies - A Pilot Study

Who this might be right for
Heart TransplantationGraft RejectionMyocardial Injury+3 more
Medical University of Vienna 50
Not applicableStudy completedNCT03438058
What this trial is testing

Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation

Who this might be right for
Organ Transplant Recipients
Paris Translational Research Center for Organ Transplantation 7,547
Not applicableStudy completedNCT00148174
What this trial is testing

Predictors and Intervention for Noncompliance

Who this might be right for
Kidney Transplantation
University of Minnesota 273
Load More Results